Scientific Program

Saturday, April 6, 2019
SYMPOSIA

IGCS PARSGO JOINED SYMPOSIUM

  • How to Motivate Patients for Clinical Trials
  • What are the Best Designs for Clinical Trials with Targeted Therapies?
  • How to Interpret Data Trials in Rare Tumors
  • Current and Future Aspects in Cervical Screening
    • The Turkish Experience
    • Global Perspectives

JOINED SYMPOSIUM: TOC, ENGOT, EUTROC, INTEGRATE

Block I: Tailored Treatment of Ovarian Cancer

  • Early Stages: Is There a Signature that Can Predict Relapse?
  • Can We Predict Response to Anti-Angiogenetic Drugs?
  • Understanding PARPi Sensitivity or Addressing Platinum Sensitivity
  • Is there a Code for Super Responder in Ovarian Cancer?

Block II: Evidence Based and Personalized Medicine: Complementary Approaches?

  • Options and Limits of New Generation Sequency for Treatment Selection
  • What are the Clinical Consequences of Tumor Profiling in Gynecological Oncology?
  • Overcoming Endocrine Resistance in Hormone Receptor Positive Breast Cancer
  • Role of PARP Therapies in Breast Cancer
  • Checkpoint Inhibitors in Breast Cancer: Who Benefits?
  • The Microbiome in Prediction of Cancer Therapy Response

Poster Session


INTENSIVE WORKSHOP CERVICAL CANCER

The Current Aspects of Cervical Cancer Therapy

Seats are limited
  • Early Cervical Cancer: How to Modify the Radicality?
  • A Sentinel Lymph Node Mapping Algorithm
  • Nerve Sparing Radical Hysterectomy: Why? And Who are the Candidates?

Program Information